NanoViricides Inc Sustainability Reports
NanoViricides, Inc. is a clinical-stage nano-biopharmaceutical company that discovers, develops, and commercializes targeted antiviral therapies. The company utilizes its proprietary nanoviricide platform technology to create drugs designed to mimic human cells to neutralize viral particles.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
LEI: 5493003CK9Y2H0OORR73
FIGI: BBG001SDFF62
12 reports from 2009 to 2024
